Immune system
Immune status and inflammatory markers are interpreted in clinical context.
+90 501 233 0002International oncology clinic — online & in-person
EXPERT-GUIDED • AI-ASSISTED
Understand your cancer — not just your reports.
We integrate imaging, pathology, laboratory findings, treatment history and expert clinical interpretation into one structured review. So you can have clearer discussions and make more informed decisions with your treating team.
Multidisciplinary clinical review
Multiple specialties. One integrated clinical perspective.
WhatsApp direct lines
25+
Years of clinical, academic & technology experience
15+
Cancer types
12+
Countries served
Expert-Reviewed
Multidisciplinary clinical review
Confidential
Your data is private and protected
Human-Guided
Real experts. Real judgment.
Timely Response
Initial review usually within 24 hours
From confusion to confidence
One clear path forward.
01The problem
Overwhelmed by complex reports and uncertainty.
Reports, scans and results from different places — hard to piece together.
02The solution
OncoXAI brings everything together.
We connect the dots across your medical data and timeline.
03The result
From uncertainty to clarity and confident next steps.
A single integrated review you can act on with confidence.
The problem
Medical data is scattered and hard to understand.
Reports, scans and lab results rarely speak the same language.
Before
MRI Brain with Contrast
mri_brain_2024_03.pdf
PET-CT Report
petct_report_2024_03.pdf
Pathology Report
pathology_2024_03.pdf
Blood Test Results
labs_2024_03_14.csv
Genomic Report
genomics_panel_2024.pdf
Clinical Notes
handwritten_doctor_note
"Too many reports. Not enough clarity."
OncoXAI
Expert-Guided
Clinical Integration
Scattered data becomes clear insight
After OncoXAI
Clinical condition
Stable – responsive
Treatment efficacy
Strong clinical response
Risk profile
Low / monitored
Next step
Recommended next step
One report. One language. Everything you need.
Multidisciplinary review
Experts from multiple disciplines
Secure & private
Your data is protected with enterprise-grade security
Access from anywhere
Online review from anywhere in the world
Patient-first approach
Focused on what matters most to you
The full clinical picture
Your case is not one report — it's a combination of everything happening in your body.
No single report tells the whole story. Accurate clinical decisions require understanding how imaging, pathology, laboratory findings, treatment response, organ function and patient-specific factors interact as one integrated clinical picture.
We evaluate the interacting clinical factors that drive treatment decisions and outcomes.
Tumor Biology
Type, grade, molecular subtype and genomic drivers
Imaging Assessment
CT, MRI and PET-CT reviewed together over time
Pathology Review
Histology and biomarkers integrated with imaging
Biomarkers & Labs
Tumor markers and molecular signals as disease activity
Treatment Response
Is the current therapy working — where, how much, and trajectory
Treatment Tolerance
Side-effect burden and physiological reserve
Organ Function
Heart, liver, kidney and bone-marrow capacity
Quality of Life
Daily function, symptom load and what matters most to you
Tumor Biology
Type, grade, molecular subtype and genomic drivers
Imaging Assessment
CT, MRI and PET-CT reviewed together over time
Pathology Review
Histology and biomarkers integrated with imaging
Biomarkers & Labs
Tumor markers and molecular signals as disease activity
Treatment Response
Is the current therapy working — where, how much, and trajectory
Treatment Tolerance
Side-effect burden and physiological reserve
Organ Function
Heart, liver, kidney and bone-marrow capacity
Quality of Life
Daily function, symptom load and what matters most to you
Comprehensive by design
We look at the full picture, not just one piece of the puzzle.
Interconnected factors
Each factor influences the others. Context changes everything.
Expert-driven evaluation
Experienced specialists interpret the complete clinical picture.
Better decisions, better outcomes
An integrated view leads to more precise and personalized care.
CONDITIONS WE SUPPORT
Clinical clarity across a wide range of cancer types and stages.
From early-stage disease to complex metastatic cases, each review is tailored to the diagnosis, available records, treatment history and questions that need to be addressed.
Breast Cancer
Early to advanced stage
Lung Cancer
NSCLC, SCLC, metastatic
Brain & Central Nervous System
Gliomas, brain metastases and other complex CNS tumors
Colorectal Cancer
Colon, rectum, liver metastases
Liver & Biliary Tract
HCC, cholangiocarcinoma and biliary cancers
Pancreatic Cancer
All stages including locally advanced
Prostate Cancer
Localized to advanced, castration-resistant
Gynecologic Cancers
Ovarian, cervical, uterine, endometrial and others
Lymphoma & Leukemia
Hodgkin, NHL, ALL, AML and other hematologic malignancies
Head & Neck Cancers
Oral, throat, laryngeal, nasopharyngeal and others
Pediatric Cancers
Solid tumors and hematologic cancers in children and adolescents
Rare, Complex & Metastatic Cancers
Rare tumors, cancers of uncertain origin and complex metastatic disease
Every case is reviewed individually.
The diagnosis is only one part of the story. Treatment history, disease behavior, organ function, symptoms and individual clinical priorities also matter.
Don't see your diagnosis? Reach out — we cover rare and complex cases too.
How a clinical review works
Ten clinical angles. One integrated picture.
Every case is reviewed across ten essential clinical domains to understand the complete picture — not just individual test results.
Imaging Assessment
CT, MRI, PET-CT and other scans
Pathology Review
Histology slides and reports
Laboratory & Biomarkers
Blood tests, tumor markers, molecular & genomic data
Genomics & Molecular Profile
Mutations, signatures and actionable targets
Clinical History & Context
Diagnosis, treatments, timelines, outcomes
Multidisciplinary
Expert Review
Multiple specialists.
One integrated view.
Organ Function
Heart, liver, kidney, lung, bone marrow
Treatment Response
How the disease responds to therapy
Quality of Life
Symptoms, daily function and patient priorities
Immune Status
Inflammatory & immune markers
Rare & Metastatic Factors
Complex and uncommon cases
Clinical & Scientific Experience
Decades of experience behind every case we review.
OncoXAI is led by clinicians and scientists with more than two decades of academic, clinical and technological experience across North America, Europe and Asia — applied to every case we review.
A global footprint
Global collaboration.
Local expertise.
OncoXAI is built on more than 20 years of experience (since 1999) across three continents. We collaborate with leading institutions and healthcare systems in North America, Europe and Asia Pacific.
3
Continents
12+
Countries
Global
Network
North America
Europe
Asia Pacific
Since 1999
Over 25 years of clinical & scientific experience
12+
Countries across 3 continents
50+
Academic, clinical & research collaborations
200+
Peer-reviewed publications & research contributions
Academic, clinical & technology background
Our team combines senior academic and clinical experience with deep technology expertise — including leadership and research roles at global medical-technology companies such as Philips and GE HealthCare, applied here in service of patient care.
- Academic experience — university faculty, peer-reviewed research and ongoing clinical studies in oncology, radiology and imaging science.
- Clinical expertise — direct multidisciplinary case review across diverse cancer types and stages.
- Technology expertise — senior R&D and clinical-implementation roles in advanced imaging and therapy systems.
Our expertise areas
Oncology
Radiology
Neurology
Gynecology
Medical Physics & Engineering
The solution
OncoXAI brings
every answer together.
We combine all your clinical data, expert review and explainable AI to give you actionable insights — in one calm, complete report.
Built for the questions you really have.
Every report is structured around the questions patients and families ask most — answered with empathy, evidence and clarity.
Is my treatment actually working?
01What should I do next?
02Are there better options for me?
03What does all of this really mean?
04A human-centered approach
You are more than a tumor.
We evaluate the whole patient — not just the disease.
Human-centered clinical review
Organ function
Liver, kidney, heart and bone marrow function help guide treatment decisions.
Treatment tolerance
Previous treatments and physiological reserve help determine suitable options.
Quality of life & independence
Symptoms, daily function and patient priorities are considered alongside medical findings.
Whole-patient assessment
Beyond the tumor, beyond the scan, beyond the pathology.
Organ function considered
Every major system is evaluated for safer, smarter decisions.
Patient-first communication
Clear explanations that help you and your family feel confident.
Behind every review
Multidisciplinary Experts.
Every report is reviewed by experienced clinical specialists. AI supports the process, but medical judgment always comes from experts.
Medical Oncology
Treatment strategy, systemic therapy planning and outcome prediction.
Radiology
MRI, CT and PET-CT interpretation and longitudinal disease monitoring.
Pathology
Tissue diagnosis, histology review and biomarker integration.
Molecular Biology
Genomic profiling, subtype classification and target identification.
Nutrition
Nutritional assessment, metabolic support and treatment tolerance.
Psychology
Patient well-being and quality-of-life assessment and support.
Medical Physics
Imaging science, quantitative analysis and clinical technology integration.
AI Decision Support
Supports data organization, pattern recognition and cross-checking under expert supervision.
Clinical experts lead
Every case is reviewed by experienced specialists.
AI assists, not decides
Advanced tools support analysis and ensure nothing is missed.
Human judgment first
Final interpretation and recommendations always come from our experts.
Technology accelerates the review. Clinical experts make the decisions. Patients benefit.
Your report
A report you can actually understand.
Every OncoXAI review brings together imaging, pathology, laboratory results, treatment history and expert clinical interpretation into one clear, personalized clinical review.
Imaging & pathology summaries in one place
Everything connected, side by side.
Biomarker results explained in context
What they mean for your specific situation.
Treatment history with visual timeline
See the full story, at a glance.
Expert interpretation in plain language
Clear, concise and focused on what matters.
Personalized next steps, clearly outlined
Actionable recommendations you can discuss with your care team.
Multidisciplinary Case Review
Patient Review — Sample Report
ID 2025-0278-08872 · Reviewed 12 May 2025
Imaging Summary
CT chest/abdomen/pelvis + contrast-enhanced MRI
A 3.2 cm mass is identified in the right upper lobe with mild surrounding ground-glass opacity. No pleural effusion or significant mediastinal lymphadenopathy. MRI confirms solitary lesion with no evidence of distant metastasis.
Solitary lesionNo distant metsNo M0
Pathology Summary
Moderately differentiated adenocarcinoma
Core biopsy confirms invasive adenocarcinoma with acinar pattern. Tumor cells show mild to moderate pleomorphism. Lymphovascular invasion not identified. Margins of biopsy specimen are uninvolved.
Grade 2pT2Margins negative
Biomarkers
PD-L1
35%
Positive
EGFR
Wild-type
Not Detected
ALK
Negative
Not Detected
KRAS
G12C
Mutation
Other
No actionable alterations
Organ Function
Liver, kidney, heart and bone marrow functions are within expected ranges.
StableImmune Status
No evidence of immune suppression. Inflammatory markers within acceptable limits.
BalancedTreatment Tolerance
Good performance status (ECOG 1). Suitable for standard and targeted therapeutic options.
FavorableQuality of Life
Patient is active, independent in daily activities with good support system.
PreservedClinical Correlation
All findings integrated with clinical history for a complete patient picture.
Complete Integrated Clinical Interpretation
The imaging and pathology findings are concordant: a moderately differentiated adenocarcinoma with PD-L1 positivity and KRAS G12C mutation. No distant metastasis is detected. The patient showed partial response to neoadjuvant therapy. Overall, the disease is locoregional and potentially curable with multidisciplinary management.
Treatment History Timeline
Jan 2025Initial diagnosis & staging
Feb 2025Neoadjuvant chemotherapy Cycle 1-4
Mar 2025Restaging scan Partial response
Apr 2025Multidisciplinary review
May 2025Current review & plan
Personalized Next Steps
1Surgical oncology consultation for definitive resection
2Pre-operative cardiopulmonary risk assessment
3Post-surgery multidisciplinary tumor board review
4Consider adjuvant immunotherapy based on PD-L1 status
In plain words: Imaging and biopsy show a single, treatable lung tumor with no spread to other organs. The tumor responded well to initial chemotherapy. Surgery is the next step, followed by a review of whether additional therapy is needed. A clear, step-by-step plan is in place.
Online consultation
Talk to a real expert. Ask anything.
Every case is reviewed by a multidisciplinary team of specialists — not an algorithm alone. AI-assisted. Expert-reviewed. Always.
You
What does my MRI result really mean?Dr. Marquez, Oncologist
Your scan shows your tumor is responding to treatment — let me walk you through it.You
Should I be worried about side effects?Patient stories
Trusted by patients.
Proven by outcomes.
Real experiences from people who received multidisciplinary clinical reviews and found clarity, confidence and direction.
4.9
1,284 Google reviews
Real people. Real stories. Real impact.
We are honored to support patients and families on their journey with clarity, compassion and expert guidance.
Your data is safe with us
Secure & Confidential
Your data is encrypted and handled with the highest security standards.
GDPR Compliant
We follow strict EU data protection regulations and guidelines.
Human Reviewed
Your case is reviewed by experienced specialists, not by algorithms.
Global & Multilingual
We serve patients worldwide in multiple languages with cultural sensitivity.
When do patients come to OncoXAI?
Every patient has a reason.
Every reason deserves clarity.
People come to OncoXAI at different moments in their journey when they need clear answers and expert guidance.
New diagnosis
You just received a diagnosis and need to understand what it means and what comes next.
Disease progression
Your disease has changed or advanced and you need a clearer picture of your current status.
Conflicting medical opinions
You've received different opinions and want an independent, multidisciplinary review.
Complex pathology results
Your pathology or molecular results are complex and need expert interpretation.
Treatment uncertainty
You are unsure about the best treatment path and need evidence-based guidance.
Need for a second opinion
You want an additional expert perspective before making an important decision.
ONE UPLOAD. ONE MULTIDISCIPLINARY REVIEW.
Before making your next treatment decision, understand the complete clinical picture.
1. Upload
Send your medical reports and images securely.
2. We review
Our multidisciplinary experts analyze and integrate all your information.
3. You receive
Get one clear, personalized report with expert recommendations.
It's safe, simple and confidential.